- Home
- VSTM vs CEPF Comparison
VSTM vs CEPF Comparison
Compare VSTM & CEPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- CEPF
- Stock Information
- Founded
- VSTM 2010
- CEPF 2021
- Country
- VSTM United States
- CEPF United States
- Employees
- VSTM N/A
- CEPF N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- CEPF Blank Checks
- Sector
- VSTM Health Care
- CEPF Finance
- Exchange
- VSTM Nasdaq
- CEPF Nasdaq
- Market Cap
- VSTM 581.6M
- CEPF 580.3M
- IPO Year
- VSTM 2012
- CEPF 2025
- Fundamental
- Price
- VSTM $8.00
- CEPF $10.44
- Analyst Decision
- VSTM Strong Buy
- CEPF
- Analyst Count
- VSTM 9
- CEPF 0
- Target Price
- VSTM $13.38
- CEPF N/A
- AVG Volume (30 Days)
- VSTM 2.9M
- CEPF 220.4K
- Earning Date
- VSTM 11-04-2025
- CEPF 01-01-0001
- Dividend Yield
- VSTM N/A
- CEPF N/A
- EPS Growth
- VSTM N/A
- CEPF N/A
- EPS
- VSTM N/A
- CEPF N/A
- Revenue
- VSTM $13,379,000.00
- CEPF N/A
- Revenue This Year
- VSTM $88.60
- CEPF N/A
- Revenue Next Year
- VSTM $416.99
- CEPF N/A
- P/E Ratio
- VSTM N/A
- CEPF N/A
- Revenue Growth
- VSTM 33.79
- CEPF N/A
- 52 Week Low
- VSTM $3.46
- CEPF $10.09
- 52 Week High
- VSTM $11.25
- CEPF $10.67
- Technical
- Relative Strength Index (RSI)
- VSTM 43.46
- CEPF N/A
- Support Level
- VSTM $7.55
- CEPF N/A
- Resistance Level
- VSTM $10.09
- CEPF N/A
- Average True Range (ATR)
- VSTM 0.64
- CEPF 0.00
- MACD
- VSTM -0.09
- CEPF 0.00
- Stochastic Oscillator
- VSTM 16.54
- CEPF 0.00
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About CEPF Cantor Equity Partners IV Inc. Class A Ordinary Shares
Cantor Equity Partners IV Inc is a blank check company.